1. The role of cells and their products in respiratory drug delivery: the past, present, and future
- Author
-
Sean D McCarthy, Claire Masterson, Daniel O'Toole, and John G. Laffey
- Subjects
Modern medicine ,Cell ,Pharmaceutical Science ,02 engineering and technology ,Computational biology ,030226 pharmacology & pharmacy ,Extracellular vesicles ,Cell therapy ,Extracellular Vesicles ,03 medical and health sciences ,Drug Delivery Systems ,0302 clinical medicine ,medicine ,Animals ,Humans ,Drug Carriers ,business.industry ,Proteins ,021001 nanoscience & nanotechnology ,Microvesicles ,Respiratory drug delivery ,MicroRNAs ,medicine.anatomical_structure ,Drug delivery ,0210 nano-technology ,Drug carrier ,business - Abstract
Introduction Cell-based delivery systems offer considerable promise as novel and innovative therapeutics to target the respiratory system. These systems consist of cells and/or their extracellular vesicles that deliver their contents, such as anti-microbial peptides, micro RNAs, and even mitochondria to the lung, exerting direct therapeutic effects. Areas covered The purpose of this article is to critically review the status of cell-based therapies in the delivery of therapeutics to the lung, evaluate current progress, and elucidate key challenges to the further development of these novel approaches. An overview as to how these cells and/or their products may be modified to enhance efficacy is given. More complex delivery cell-based systems, including cells or vesicles that are genetically modified to (over)express specific therapeutic products, such as proteins and therapeutic nucleic acids are also discussed. Focus is given to the use of the aerosol route to deliver these products directly into the lung. Expert opinion The use of biological carriers to deliver chemical or biological agents demonstrates great potential in modern medicine. The next generation of drug delivery systems may comprise 'cell-inspired' drug carriers that are entirely synthetic, developed using insights from cell-based therapeutics to overcome limitations of current generation synthetic carriers.
- Published
- 2020
- Full Text
- View/download PDF